Abiopharma

New Form 4/A - Viridian Therapeutics, Inc.\DE <b>Filed:</b> 2026-03-09 <b>AccNo:</b> 0001193125-26-099008 <b>Size:</b> 5 KB

ROTHBLATT MARTINE A 🟡 adjusted position in 9.5K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $487.98 ($7.4M) Transaction Date: Mar 05, 2026 | Filing ID: 000005

📋 THOMAS CATINAZZO (Officer) plans to sell 53K shares of RELAY THERAPEUTICS INC (at $9.89 each, total $526K) Filed: Mar 09, 2026 | ID: 002370

New Form 4/A - Viridian Therapeutics, Inc.\DE <b>Filed:</b> 2026-03-09 <b>AccNo:</b> 0001193125-26-099007 <b>Size:</b> 5 KB

Serota Scott Philip 🟢 acquired 2.6K shares of HENRY SCHEIN INC (HSIC) Transaction Date: Mar 06, 2026 | Filing ID: 000002

Terrill Damon 🟢 acquired 148.0K shares (1 derivative) of Alpha Teknova, Inc. (TKNO) at $1.99 Transaction Date: Feb 15, 2026 | Filing ID: 000002

Mack David Henry 🟢 acquired 745.0K shares (1 derivative) of PMV Pharmaceuticals, Inc. (PMVP) at $1.53 ($1.1M) Transaction Date: Mar 05, 2026 | Filing ID: 000002

(70% Positive) TREVI THERAPEUTICS, INC. (TRVI) Announces Clinical Development Update

ARCH Venture Fund XIII, L.P. 🟢 acquired 488.1K shares of Lyell Immunopharma, Inc. (LYEL) at $25.61 ($12.5M) Transaction Date: Mar 06, 2026 | Filing ID: 000234

📋 NATHAN DOWDEN (Officer) plans to sell 15K shares of ENTRADA THERAPEUTICS INC (at $12.58 each, total $189K) Filed: Mar 09, 2026 | ID: 002366